Integrins are cell-surface heterodimers formed by the association of one a-and one /8-subunit. Glycoprotein Illa (GPIIIa or /33 subunit) is the common fl-subunit of the /33 subfamily of integrins, which, when associated with glycoprotein Ilb (GPIIb), constitutes the receptor for fibrinogen and other adhesive proteins at the platelet surface (the GPIIb-IIIa complex) and, when associated with the av subunit, constitutes the vitronectin receptor present in several cell types. Protein chemical analysis of GPIIIa allows us to define the following structural domains: the cysteine-rich and proteinaseresistant N-terminal domain (GPIIIa 1-62); the adhesive-protein-binding domain (GPIIIa 101-422); the cysteine-rich and proteinase-resistant core (GPIIIa 423-622); and the C-terminal domain comprising an extracellular subdomain (GPIIIa 623-692), a transmembrane subdomain (GPIIIa 693-721), and a cytoplasmic subdomain (GPIIIa 722-762). We also assign unambiguously the disulphide bonds within the N-terminal, the fibrinogen-binding and the C-terminal domains, and the two long-range disulphide bonds which join the N-terminus to the proteinase-resistant core (Cys5-Cys435) and the fibrinogen-binding domain to the extracellular side of the C-terminal domain (Cys406-Cys655). In addition, we propose three alternative models for the arrangement of the disulphide bonds within the core and of the disulphide bonds joining the core to the extracellular side of the C-terminal domain, consistent with our experimental findings, favouring temporarily that which imposes less steric hindrance for the formation of these disulphide bonds.
INTRODUCTION
The term 'integrin' has recently been coined for the members of a family of cell-adhesion receptors functionally implicated in cell-substratum and cell-cell interactions and, therefore, in biological processes so diverse as haemostasis, embryogenesis, immunological recognition, wound healing, and tumour metastasis (Hynes, 1987) . Individual integrins, expressed at the cell surface and consisting of heterodimers of non-covalently associated a-and /-subunits, have been divided into subfamilies based on the presence of distinct, but sequence-related, f-subunits (/1, /32, ,/3, ,/4 and /35) (Hynes, 1987; Rouslahti & Pierchbacher, 1987; Kajiji et al., 1989; Ramaswamy & Hemler, 1990) . Each ,-subunit can associate with one of a number of ax-subunits, enlarging the diversity of the integrin family further. Two members comprise, so far, the /33 subfamily (Fitzgerald et al., 1987) , the platelet GPIIb-IIIa complex and the vitronectin receptor, expressed, among others, by endothelial and melanoma cells (Pytela et al., 1985; Cheresh, 1987; Cheresh & Spiro, 1987) .
The GPIIb-IIIa complex, a Ca2l-dependent heterodimer formed by glycoproteins Ilb (GPIIb) and Illa (GPIIIa or /33), is the major integrin at the platelet surface, which, after platelet activation, serves as the main fibrinogen receptor as well as the receptor for other adhesive proteins and, therefore, plays a primary role in platelet adhesion and aggregation (Bennett et al., 1982; Nachman & Leung, 1982; Ruggeri et al., 1983; Plow et al., 1985; Thiagarajan & Kelly, 1988) . In the last few years, the cDNA-derived amino acid sequence has been determined for most of the a-and /3-subunits of the integrin family, among them GPIIb and GPIIIa (Fitzgerald et al., 1987; Poncz et al., 1987; Rosa et al., 1988; Heidenreich et al., 1990; Zimrin et al., 1990) . GPIIb (136 kDa) is a platelet-specific, bitopic, disulphidebonded two-chain a-subunit whose covalent structure is mainly known (Calvete et al., 1989; Calvete et al., 1990a,b) , and whose topography is beginning to be revealed (Lam et al., 1989; Calvete et al., 1991a) . GPIIIa (92 kDa) is a bitopic single-chain /3-subunit, highly cross-linked by 28 disulphide bonds, whose covalent structure is mostly unknown and whose topography at the N-terminal region is becoming known (Calvete et al., 1988; D'Souza et al., 1988; Beer & Coller, 1989; Niewiarowski et al., 1989; Pasqualini et al., 1989; Calvete et al., 1991b) . Taking all this information together w'e have been able to outline four main structural domains in GPIIIa: the N-terminal cysteine-rich domain; the fibrinogen-binding domain, comprising at least the GPIIIa 100-348 sequence stretch; the cysteine-rich proteinaseresistant core, which is bound to the N-terminal domain by a single disulphide bond; and the C-terminal domain, comprising at least the transmembrane and the short cytoplasmic subdomains.
In the present work, and using protein chemical methods, we have been able to define more precisely the limits of the four structural domains referred to above and to assign unambiguously the disulphide bonds within the N-terminal, the fibrinogen-binding and the C-terminal domains, and the two long-range disulphide bonds which join the N-terminal domain to the N-terminal side of the proteinase-resistant core, and the Cterminal side of the fibrinogen-binding domain to the extracellular side of the C-terminal domain of GPIIIa respectively. In addition, we propose a cysteine-pairing pattern for the proteinase-resistant core and for the disulphide bonds joining the Vol. 274 63 Abbreviations used: GPIIb and GPIIIa, platelet glycoproteins Ilb and Ila; CM-GPIIIa, fully reduced and carboxymethylated GPIIIa; Tos-PheCH2Cl-trypsin, tosylphenylalanylchloromethane('TPCK')-treated trypsin; TFA, trifluoroacetic acid.
I To whom correspondence and reprint requests should be sent. morpholine, pH 8.0 (NH4HCO3 buffer) was treated with TosPhe-CH2Cl-trypsin at an enzyme/glycoprotein ratio of 1:250 (w/w) for 45 min at 37 'C. The tryptic products were fractionated on a Sephacryl S-200 column (85 cm x 1.6 cm) using 0.1 M-sodium phosphate/ I mM-EDTA, pH 6.8, containing 0.1 0% SDS and 0.025 % NaN3 (phosphate buffer) as elution buffer. The major tryptic fraction (70 kDa), after extensive dialysis against Milli Q water, was freeze-dried and further solubilized (5 mg/ml) in 50 mM-Tris/HCl/ I mM-EDTA/0. 0 % SDS, pH 8.0 (Tris buffer) and reduced with dithioerythritol (0.1 mm final concn.)
for 1 h at room temperature. Afterwards the thiol groups formed were alkylated with a 1.5-fold molar excess of eosin-5-maleimide over reducing agent for 15 min, at room temperature and in the dark. The alkylated sample was diluted with Milli Q water to bring the SDS concentration below its critical micellar concentration (Usobiaga et al., 1987) , and the unbound dye was separated by passage through a column (50 cm x 1.6 cm) of Sephadex G-50 equilibrated in 20 mM-phosphate/0.025 % SDS, pH 6.8. The eosin-labelled peptides (50 kDa and 17 kDa) were isolated on Sephacryl S-200 as described above.
The 50 kDa fragment was subsequently fully reduced with a 150-fold molar excess of dithioerythritol over its cysteine content, and the new thiol groups formed alkylated with 4-vinylpyridine. After extensive dialysis against Milli Q water, the sample was freeze-dried. Part of the sample (10 mg/ml) was cleaved with CNBr (100 mg/ml) in 70 % (v/v) formic acid, under N2 and in the dark. After 4 h at room temperature the mixture was diluted with Milli Q water and freeze-dried. The rest of the sample was further digated with Tos-Phe-CH2Cl-trypsin at an enzyme/ peptide ratio of 1:25 (w/w) in NH4HCO3 buffer for 16 h at 37°C, and the tryptic products were isolated by reverse-phase h.p.l.c. on a C4 (pore size 30 nm, particle size 10 m) Vydac column (25 cm x 0.6 cm) equilibrated in a mixture of 0.1 % trifluoroacetic acid in water (A) and 0.1 % trifluoroacetic acid (TFA) in acetonitrile (B) (100 % A/0 % B) and eluted at 1 ml/min, first isocratically for 5 min followed by a linear gradient up to 70 % B in 70 min.
The 17 kDa fragment from the Sephacryl 200 column was further digested with Tos-Phe-CH2CI-trypsin at an enzyme/ substrate ratio of 1:25 (w/w) for 16 h at 37°C, and the tryptic products isolated by reverse-phase h.p.l.c. on a C18 (pore size 30 nm, particle size 10 lim) Vydac column (25 cm x 0.46 cm) equilibrated in a TFA/water/acetonitrile mixture (80 % A/ 200% B) and eluted at 1 ml/min, first isocratically for 5 min, followed by a linear gradient up to 50 % B in 80 min. Fractions T6 and T7 from this column were successively freeze-dried, solubilized in 10 mM-triethylamine, pH 9.0, reduced with 1 % (v/v) 2-mercaptoethanol at 100°C for 2 min, alkylated with a 5-fold molar excess of 4-vinylpyridine over 2-mercaptoethanol, freeze-dried, solubilized in NH4HC03 buffer and digested with Tos-Phe-CH2Cl-trypsin at an enzyme/peptide ratio of 1:50 (w/w) for 16 h at 37 'C. The tryptic products were isolated on a C18 Vydac column equilibrated in a TFA/water/acetonitrite mixture (800% A/10 0% B) and eluted at 1 ml/min, first isocratically for 5 min, followed by a linear gradient up to 25 % of B in 25 min, and then up to 50 % of B in 75 min.
Late digestion of GPIIIa with trypsin GPIIIa (5 mg/ml) in NH4HCO3 buffer was treated with Tos-Phe-CH2CI-trypsin at an enzyme/glycoprotein ratio of 1:50 (w/w) for 16 h at 37 'C. The late tryptic products were isolated either on a Sephacryl S-200 column, as described above, or on a C18 Vydac column equilibrated in a TFA/water/ acetonitrile mixture (90% A/10% B) eluted at 1 ml/min, first isocratically for 10 min, followed by a linear gradient up to 40 % B in 110 min, and then up to 70 % B in 30 min.
The main fraction (35 kDa tryptic fragment) obtained on the Sephacryl S-200 column was extensively dialysed against Milli Q water and freeze-dried. Part of this fraction (0.5 mg) was solubilized in 10 mM-triethylamine, pH 9.0, reduced with 1% 2-mercaptoethanol for 2 min at 100 'C, alkylated with a 5-fold molar excess of 4-vinylpyridine over reductant, and either fractionated on a TSK-2000 SW (600 mm x 7.5 mm) column equilibrated and eluted with phosphate buffer, or on a C18 Vydac column equilibrated in TFA/water/acetonitrile mixture (90 % A/ 100% B), and eluted at I ml/min, first isocratically for 5 min, followed by a linear gradient up to 500% B in 85 min. Alternatively, the main fraction (35 kDa tryptic fragment) obtained on the Sephacryl S-200 column, once dialysed and freeze-dried, was digested with Tos-Phe-CH2Cl-trypsin in NH4HC03 buffer at an enzyme/peptide ratio of 1:25 (w/w) for 16 h at 37 'C. The tryptic products were fractionated on a Sephacryl S-200 column as described above. The main fraction (30 kDa fragment) was fully reduced, alkylated, and fractioned either on a TSK-2000 SW column or on a C18 Vydac column, as described above for the preparation and isolation of the full reduction and alkylation products of the 35 kDa tryptic fragment.
Chymotryptic digestion of GPIIIa
GPIIIa (5 mg/ml) in 0.1 M-Tris/HCl, pH 7.6, was digested with chymotrypsin at an enzyme/glycoprotein ratio of 1:10 (w/w) for 24 h at 37 'C, and the chymotryptic products fractionated on a Sephacryl S-200 column as described above. was extensively dialysed against Milli Q water and freeze-dried.
Part of this fraction was reduced, alkylated and fractionated as described above for the 35 kDa tryptic product of GPIIIa. Alternatively, the 35 kDa V8-proteinase-resistant fragment was solubilized in NH4HCO3 buffer and treated with Tos-Phe-CH2Cl-trypsin at an enzyme/peptide ratio of 1:50 (w/w) for 20 h at 37°C and the tryptic products isolated on a C18 Vydac column equilibrated in a TFA/water/acetonitrile (900 A/10 00 B) mixture and eluted at 1 ml/min, first isocratically for 5 min, . ' Isolation by reverse-phase h.p.l.c. of the tryptic (R-) products of the fully reduced, vinylpyridine-alkylated, eosin-labelied, 50 kDa tryptic product of early digestion of GPIIIa The fully reduced and alkylated, eosin-labelled 50 kDa tryptic product of GPIIIa, isolated as shown in Fig. l(b) , was digested with Tos-Phe-CH2Cl-trypsin (see the Materials and methods section), and the tryptic products were separated on a C4 (30 nm particle size, 5 urm pore size) Vydac column (25 cm x 0.46 cm) equilibrated in 0.1 0% TFA in water (A) and 0.1 % TFA in acetonitrile (B) (100°A /0 % B), first isocratically for 5 min, followed by a linear gradient up to 70 % B in 70min. The N-terminal sequences of the separated fractions are given in Table 1 . The stars indicate those fractions containing eosin-labelled peptides. mined after being transferred to a polyvinylidene difluoride membrane, was 388GLKIG, which suggested that the cysteine residue we were looking for was between Met387 and Met535.
On the other hand, when the fully reduced and vinylpyridinealkylated eosin-labelled 50 kDa product was further digested with Tos-Phe-CH2Cl-trypsin and the tryptic products isolated by reverse-phase h.p.l.c. (Fig. 2) and identified by amino acid and N-terminal sequence analyses (Table 1) , all the theoretically expected peptides containing cysteine, between Met387 and Met535, were recovered. Only one among them, R 13, identified with the peptide stretch 423-447, contained eosin; therefore any of the three cysteine residues in this sequence must be bound to any of the seven cysteine residues in the N-terminal domain.
To find out which of those three cysteine residues is labelled with eosin, and therefore is involved in the long-range disulphide bond, 17 Edman degradation cycles were performed to fraction R 13; the following N-terminal sequence was obtained:
GPIIIa The eosin-labelled 17 kDa product, isolated by size-exclusion chromatography after partial reduction of the 70 kDa tryptic fragment of GPIIIa (see above), was further digested with TosPhe-CH2Cl trypsin, at an enzyme/substrate ratio of 1:25 (w/w), for 16h at 37°C (see the Materials and methods section), and the tryptic products were isolated by reverse-phase h.p.l.c. (Fig. 3) Fig. l(b contained the same peptide (the GIla 1-62 sequence) and differed in the relative peptide content (1 and 1.5) and in the eosin-labelling ratio (1.1 and 1.8 mol eosin/mol of peptide respectively), which is in good agreement with the 1.8 labelling ratio of the 17 kDa peptide found above. The high proteolytic resistance of the GPIIIa 1-62 sequence, even after partial reduction and alkylation, is remarkable.
When fractions T6 and T7 were fully reduced with dithioerythritol, alkylated with vinylpyridine and digested further with Tos-Phe-CH2Cl-trypsin, at an enzyme/substrate ratio of 1:50 (w/w), for 16 h at 37°C (see the Materials and methods section), the tryptic products were isolated by reverse-phase HPLC on a C18 column. A single eosin-labelled tryptic product was isolated from T6, the N-terminal sequence and amino acid analyses of which allowed us to identify it as:
GPIIIa 1-8 GPNIXTT(R) which indicates that the first cysteine residue in the amino acid sequence of GPIIIa, Cys5, is the cysteine we were looking for, and therefore the one which, together with Cys435, disulphidebonds the N-terminal domain of GPIIIa to the N-terminal side of the proteinase-resistant core.
Cysteine pairing at the N-terminal domain of GPIIIa Three eosin-labelled tryptic products were isolated from fraction T7, whose N-terminal sequence and amino acid analyses correspond, we believe, to:
GPIIIa 1-8 GPNI XTT (R) GPIIIa47-62 DNX A P E ... GPIIIa 9-37 GVS S CQQ X LAV... Pyr which indicates that Cys49 and Cys'6 are eosin-labelled, whereas Cys13 and Cys38 are not. Therefore Cys49 could be bound to either of the three remaining cysteine residues in the GPIIIa 1-62 sequence: Cys16, Cys23 and Cys26.
To be able to assign the actual pairing of these residues, GPIIIa was digested with chymotrypsin at an enzyme/substrate ratio of 1:10, for 24 h at 37°C (see the Materials and methods section), and the chymotryptic products analysed by SDS/ PAGE. A product of apparent molecular mass Fig. 4 . Summary of the unambiguously assigned disulphide bonds in human platelet GPIIIa It is shown the cysteine-pairing within the N-terminal domain (enlarged and detailed on the right-hand side), the putative fibrinogen-binding domain and the C-terminal domain, as well as the two long-range disulphide bridges joining the N-terminal domain to the proteinase-resistant core (represented as a rectangle) and the putative fibrinogen-binding domain to the C-terminal domain respectively. *-, N-glycosylation points; -s, chymotryptic cleavage points within the N-terminal domain. labelled); and Cys26-Cys38 (Fig. 4) . A similar disulphide-bond arrangement has recently been found at the III-T2 fragment of the Von Willebrand factor (Marti et al., 1987) .
Cysteine pairing at the fibrinogen-binding domain and at the extracellular side of the C-terminal domain of GPIIIa To assign the disulphide bonds in these domains, GPIIIa was digested with Tos-Phe-CH2CI-trypsin, at an enzyme/substrate ratio of 1:50, for 16 h at 37°C and pH 8.0. Under these conditions a large fragment of apparent molecular mass 35 kDa was obtained (see below) and a set of short tryptic peptides, which were analysed by reverse-phase h.p.l.c. on a C1. column (Fig. 5) . Amino acid and N-terminal sequence analyses of the fraction obtained (TR1-TR21) allowed us to identify the isolated peptides in each of them (Table 2) . Fractions containing cysteinecarrying peptide pairs allowed us to assign the following disulphide bonds (Fig. 4) : Cys'77-Cysl84 (TR18); Cys232-Cys2"3 (TR19); Cys374-Cys386 (TR21); Cys406-Cys655 (TR17); and Cys635_Cys663 (TR12). The first three disulphides establish the nearest-neighbour pattern of cysteine pairing in the fibrinogenbinding domain. The fourth disulphide bond, Cys406-Cys655, is the other long-range disulphide in GPIIIa, which joins the C-terminal side of the fibrinogen-binding domain to the extracellular side of the C-terminal domain of GPIIIa. And the fifth, Cys"'5-Cys663, is a disulphide bond within the extracellular side of the C-terminal domain of GPIIIa.
The 35 kDa tryptic fragment of GPIIIa (see above) was isolated by size-exclusion chromatography on a Sephacryl S-200 column The Table shows the N-terminal sequences of the tryptic fragments (TRI-TR21) of the late tryptic digestion of GPIIIa, prepared and isolated as shown in Fig. 5 , and numbered according to their order of elution from the C18 reverse-phase column. On the right-hand side of the Table is the numbering in the cDNA sequence of the terminal residues of each peptide ('cDNA sequence'), assigned after N-terminal-sequence and amino-acid analysis. Sequence  cDNA sequence   TRI   TR2   TR3   TR4  TR5   TR6  TR7   TR8   TR9  TRIO  TRIl   TR12   TR13  TR14  TR15  TR16  TR17   TR18   TRl9   TR20 TR21 This means that these three peptide stretches are disulphide-bonded to the 423-622 stretch in GPIIIa, and thus confirming the Cys5-Cys435 long-range disulphide bond and showing that the extracellular side of the C-terminal domain is twice disulphide-bonded to the proteinase-resistant core by means of Cys631 and Cys687. These results are very similar to those described above after chymotrypsin digestion and to those found after thermolysin or V8-proteinase digestion of GPIIIa.
Fragment
A second tryptic digestion of the isolated 35 kDa tryptic fragment [trypsin/fragment ratio 1:25 (w/w) for 16 h at 37°C] breaks it down to a 30 kDa fragment, which was isolated on a Sephacryl S-200 column and found to contain three N-terminal sequences. The fully reduced and alkylated 30 kDa fragment was further fractionated on a TSK-2000 column and a major peptide isolated that, after amino-acid-and N-terminal-sequence analyses, was identified with the GPIIIa 423-600 peptide stretch (DSLIVQVT...) and, therefore, with the proteinase-resistant core. When the fully reduced and alkylated 30 kDa fragment was alternatively fractionated by reverse-phase h.p.l.c. on a C18 column, two peptides were isolated that, after amino-acid-and N-terminal-sequences analyses, were identified with GPIIIa 1-8 [GPNIXTT(R)] and 623-633 (GALHDEN...) peptide stretches. This means that these two peptides are disulphide-bonded to the proteinase-resistant core, confirming, once more, the Cys5-Cys435 long-range disulphide bond and the cross-linking of the extracellular side of the C-terminal domain to the core by means of Cys631. Moreover, given that the GPIIIa 677-689 peptide has no trypsin cleavage point within it, its tryptic liberation from the core, during the tryptic digestion of the 35 kDa tryptic fragment, has to take place by cleavage of a peptide within the 423-622 sequence, which has an uneven number of cysteine residues and is flanked by two trypsin cleavage points. This peptide has to be the GPIIIa 601-622 stretch, which has five cysteine residues and is cleaved from the C-terminus of the 426-622 core at the time of the 677-689-peptide-sequence release. Therefore, one of the cysteine residues (at position 601, 604, 608, 614 or 617) in the 601-622 stretch has to be disulphide-bonded to Cys687 within the GPIIIa 677-689 stretch, and the rest of them must form two disulphide bonds among themselves.
Disulphide-bond assignment in the proteinase-resistant core of
GPIIIa
Among several attempts to cleave the proteinase-resistant core of GPIIIa to reach full assignment of the disulphide bonds within it, two were partially successful, and were based either on sequential digestion of the core with different proteinases or on partial reduction and alkylation of GPIIIa followed by tryptic digestion. The second attempt to cleave the proteinase-resistant core consisted, first, in a partial reduction of GPIIIa (5 mg/ml) in 50 mM-NH4HCO3/l mM-dithioerythritol/0. I % SDS, pH 8.0, for 1 h at room temperature, followed by alkylation with a 1.5 molar excess of eosin-5'-maleimide (iodoacetamide) over dithioerythritol, gel filtration on Sephadex G-50 to separate labelled GPIIIa from free dye, and dialysis against the original buffer. Then part of the sample was fully reduced with 2-mercaptoethanol, alkylated with 4-vinylpyridine, dialysed against the original buffer, and digested again with Tos-Phe-CH2Cl-trypsin, at a trypsin/GPIIIa ratio of 1:25 (w/w) for 16 h at 37 'C. Reverse-phase h.p.l.c. peptide mapping, amino-acid-and N-terminal-sequence analyses, and eosin/peptide molar-ratio determination of the tryptic peptides showed that GPIIIa cysteine residues (5; 232; 273; 374; 386; 435; one among 501, 503, 506, 508; 521; one among 601, 604, 608; 614; 617; and 687) are at least partially labelled with eosin. Besides confirming previous findings, these results suggest that Cys52' is disulphide-bonded to any of the cysteine residues within the 501-508 stretch, because the rest of the labelled cysteine residues are either already assigned to established disulphide bonds (Cys5-Cys435; Cys232-Cys273; Cys374_Cys386) or have been found forming groups of disulphide pairs among themselves (Cys601, Cys604, Cys608, Cys614, Cys617 and Cys687).
The rest of the sample of partially reduced, eosin-labelled GPIIIa was directly digested with Tos-Phe-CH2Cl-trypsin, at a trypsin/GPIIIa ratio of 1: 25 (w/w) for 16 h at 37 'C. The tryptic products were isolated by reverse-phase h.p.l.c., analysed for amino acid composition, N-terminal sequence and eosin/peptide molar ratio, and the following peptides were identified:
GPIIIa 520-530 Y C E X D D F S X V (R) eosin which, given that Cys52' is eosin-labelled (see above), indicates that Cys523 and Cys528 are most probably disulphide-bonded between themselves, as was subsequently ascertained by full reduction, alkylation with vinylpyridine and N-terminal-sequence analysis of this peptide:
GPIIIa 581-600 XEX G (S) XVXI Q. Summarizing the experimental data on the proteinase-resistant core, we have assigned two disulphide bonds, Cys433-Cys437 and Cys523-Cys528. In the first cysteine-rich repeat of GPIIIa we have established that cysteine residues 448, 457, 460 and 495 form two disulphide bonds among themselves and that cysteine residues 462, 471, 473 and 486 are also paired among themselves. We have also shown that Cys521 is disulphide-bonded to any of the cysteine residues 501, 503, 506 or 508, in the second cysteine-rich repeat, and we have in addition established that, in the fourth cysteine-rich repeat, cysteine residues 581, 583, 586, 588, 598 and 631 form three disulphide bonds among themselves, and that cysteine residues 601, 604, 608, 614, 617 and 687 are also paired among themselves. In Fig. 6 The cysteine-rich repeat sequences are aligned with their cysteine residues in register, and the highly conserved sequence-stretches are underlined. Assigned disulphide bonds or groups of cysteine residues paired among themselves are boxed. rich repeats of the proteinase-resistant core are shown, aligned with their eight cysteine residues in register, together with the experimental results found here. It can be observed that the first cysteine-rich repeat has an extra amino-acid-sequence stretch in between the first two cysteine residues (Cys448 and Cys457) and that the first four cysteine residues of the fourth repeat are in register, whereas the last four are not. If we combine the information gathered in Fig. 6 with the assumption that all the cysteine residues within each repeat are paired among themselves, and that the pairing pattern is the same in each repeat, then the following conclusions can be drawn. The fourth cysteine residue in each repeat should be bound to the fifth, and the sixth to the seventh, being the first three cysteine residues together with the eighth paired among themselves. There are three cysteine-pairing possibilities: lst-2nd, 3rd-8th; 1st-3rd, 2nd-8th; and 1st-8th, 2nd-3rd. In Fig. 7 we outline the disulphide-bond pattern for GPIIIa, favouring the last cysteine-pairing possibility for steric reasons, and at the side we list the three alternatives. Further experimental evidence is required to ascertain the definitive disulphide-bond pattern within each cysteine-rich repeat and the pairing of cysteine residues 608, 614, 617 and 687.
Disulphide-bond pattern for the fl-subunits of the integrin family In all known /3-subunits of the intregrin family, except /34, from man down to Drosophila, there are certain structural and functional features which are becoming apparent and which are highly maintained overall: the size, about 760 amino acids; the single transmembrane domain; the short cytoplasmic domain of about 40-50 amino acids; the position and number of the 56 cysteine residues; the four cysteine-rich repeats; the highly similar amino acid sequences within the 100-350-peptide stretch; the location of the adhesive-protein-binding domain in the 100-350-peptide stretch, which most probably is not involved in the interaction with the corresponding subunit to form the heterodimer, the integrin; the presence of a putative tyrosine phosphorylation site in the cytoplasmic domain. So far, only one exception to this general pattern is known: the /34 subunit of a recently found integrin (Kajiji et al., 1989) whose amino acid sequence has just been derived from its cDNA (Suzuki et al., 1990; & Hogervost et al., 1990) . This ,/4 subunit has a molecular mass more than double that of the other /-subunits, four cysteinerich repeats, but only 48 cysteine residues in the extracellular domain, and has a cytoplasmic domain more than twenty times the size of the cytoplasmic domain of the other /3-subunits.
On the basis of this highly conserved overall structure, we propose to extend the cysteine-pairing pattern outlined here for GPIIIa (/33) (Fig. 7) to all the /-subunits of the integrin family, as well as to define in them the following domains: the Nterminal, cysteine-rich and proteinase-resistant domain (GPIIIa 1-62); the adhesive-protein-binding domain ; the cysteine-rich proteinase-resistant core ; and the C-terminal domain, comprising an extracellular side subdomain (GPIIIa 623-692), a transmembrane subdomain , and cytoplasmic subdomain . Finally, there is no apparent correlation between the exon boundaries in the GPIIIa gene (Heidenreich et al., 1990) and the domain organization outlined here (Fig. 7) . 
